Abstract:This study explores the effectiveness of the antineoplastic agent 5-FU in cancer cells by leveraging the unique properties of cationic antimicrobial peptides (CAMPs) and cell-penetrating peptides (CPPs). Traditional anticancer therapies face substantial limitations, including unfavorable pharmacokinetic profiles and inadequate specificity for tumor sites. These drawbacks often necessitate higher therapeutic agent doses, leading to severe toxicity in normal cells and adverse side effects. Peptides have emerged as promising carriers for targeted drug delivery, with their ability to selectively deliver therapeutics to cells expressing specific receptors. This enhances intracellular drug delivery, minimizes drug resistance, and reduces toxicity. In this research, we comprehensively evaluate the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of various AMPs and CPPs to gain insights into their potential as anticancer agents. The peptide synthesis involved a solid-phase synthesis using a Liberty Microwave Peptide Synthesizer. The peptide purity was confirmed via LC-MS and HPLC methods. For the ADMET screening, computational tools were employed, assessing parameters like absorption, distribution, metabolism, excretion, and toxicity. The cell lines A549 and UM-UC-5 were cultured and treated with 5-FU, CAMPs, and CPPs. The cell viability was measured using the MTT assay. The physicochemical properties analysis revealed favorable drug-likeness attributes. The peptides exhibited potential inhibitory activity against CYP3A4. The ADMET predictions indicated variable absorption and distribution characteristics. Furthermore, we assessed the effectiveness of these peptides alone and in combination with 5-FU, a widely used antineoplastic agent, in two distinct cancer cell lines, UM-UC-5 and A549. Our findings indicate that CAMPs can significantly reduce the cell viability in A549 cells, while CPPs exhibit promising results in UM-UC-5 cells. Understanding these multifaceted effects could open new avenues for antiviral and anticancer research. Further, experimental validation is necessary to confirm the mechanism of action of these peptides, especially in combination with 5-FU.

Use Of Antitumor Peptides And Herbal Compounds As Antineoplastic Agents.

Use Of Anti-Tumor Peptides In Head And Neck Cancer.

Antimicrobial-Antitumoral Peptides. Potencial Molecules To Treat Oral Cancer And Bacterial Infections: Systematic Review.

From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds

From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides

Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment

Nature's weapons: Bioactive compounds as anti-cancer agents

Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective

The Combination Of Peptides And Cisplatin For The Treatment Of Oral Cancer.

Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment

Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges

New Perspective for Using Antimicrobial and Cell-Penetrating Peptides to Increase Efficacy of Antineoplastic 5-FU in Cancer Cells

Bioactive peptides: an alternative therapeutic approach for cancer management

Phytocompounds and Nanoformulations for Anticancer Therapy: A Review

Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents

Nano-based apigenin delivery systems for cancer applications

Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy

Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy

Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes

Monoterpene indole alkaloids with anticancer activity from Tabernaemontana species

Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies